IPO Global ResearchIPO Global Research
10/23/2014 Thursday
Buy Market Research on: Medrx 4586-JP (Japan)
Please read the disclaimer before continuing with your IPO market research purchase

IPO Global Research aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users, but we cannot assure absolute accuracy.

Investing in the public stock market is risky and market conditions change regularly. Readers should consult with professional investment advisors and conduct their own research before acting on information published by IPO Global Research. We encourage our readers to invest carefully and study the educational information available at the web sites of the Securities and Exchange Commission ("SEC") (www.sec.gov) and the National Association of Securities Dealers ("NASD") (www.nasd.com).

Comments on IPO Global Research, including our e-mail alerts and advisories are the observations of the staff of IPO Global Research. They are not intended to be absolute recommendations to buy, hold or sell securities but carefully chosen advisory information, or an endorsement of any specific security or trading strategy. We cannot guarantee the success of any action taken in reliance on statements made in IPO Global Research.

IPO Global Research, and its affiliates may own stock, purchase stock in the companies mentioned on our website and may elect to increase or decrease the size of these positions at any time. However, we are not compensated in any way for publishing information about subject companies.

IPO Global Research shall not be liable for any direct, indirect, incidental, special or consequential damages resulting from the use of our website and publications or resulting from unauthorized access to or alteration of users' transmissions or data, including but not limited to, damages for loss of profits, use or data, even if IPO Global Research has been advised of the possibility of such damages.

IPO Global Research expressly disclaims all warranties of any kind, express or implied, including without limitation any warranty of merchantability or fitness for a particular purpose. Use of our website or publications is provided on an "as is" basis. IPO Global Research content is not to be shared, exchanged or sold to any party or entity. Any violations may cause us to initiate legal action or otherwise. Upon entering a subscription or an individual one time market research buy to IPO Global Research it can NOT be canceled for any reason for at least the duration they have elected. There will not be any pro-rated reimbursements for any reason. Any monthly subscription that the client has chosen to cancel must be brought to our attention at least 48 hours (forty eight) in advance of their monthly cycle conclusion or they will be billed automatically for the next billing cycle. Under no circumstances can an annual subscriber cancel prior to their annual expiration date, and expect ANY financial remuneration to be reimbursed or considered. It should be noted that under either subscription method (monthly or annual) our billing service AUTOMATICALLY will rebill on the anniversary date of your subscription choice-unless notified in writing by the client.

If you have any questions or need additional information or clarification about this disclaimer, please send us an e-mail (see our contact information for more details).



Check here indicating you have read our disclaimer and agree:

© 2014 IPO Global Research. All Rights Reserved